Meta‐analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation
Alimentary Pharmacology & Therapeutics · 2024
DOI: 10.1111/apt.17952 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von Asif A Hitawala und 10 weiteren Autor:innen. Beteiligte Einrichtung: Liver Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Fontan Procedure, Carcinoma, Hepatocellular, Liver Neoplasms, Liver Cirrhosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA, National Institutes of Health Library, Office of Research Services in support of the NIH Intramural Research Program, National Institutes of Health, Bethesda,…, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Background and Aims The Fontan palliation is the final stage of surgery for many children born with univentricular physiology. Almost all Fontan patients develop liver fibrosis which may eventually lead to cirrhosis and hepatocellular carcinoma (HCC). These are important causes of morbidity and mortality in these patients. We performed a systematic review and meta‐analysis to assess the incidence of cirrhosis and HCC in Fontan patients and stratify it based on time since surgery.
Methods
A literature search of seven databases identified 1158 records. Studies reporting the number of cirrhosis and HCC cases in Fontan patients and time since Fontan surgery were included. In the cirrhosis cohort, we included only those studies where all patients underwent liver biopsy.
Results
A total of 23 studies were included: 12 and 13 studies in the cirrhosis and HCC cohorts, respectively, with two studies included in both cohorts. The incidence of cirrhosis was 0.97 per 100 patient‐years (95% CI 0.57–1.63), with the incidence and cumulative incidence ≥20 years post Fontan surgery being 1.61 per 100 patient‐years (95% CI 1.24–2.08) and 32.2% (95% CI 25.8%–39.4%), respectively. The incidence of HCC was 0.12 per 100 patient‐years (95% CI 0.07–0.21), with the incidence and cumulative incidence ≥20 years post Fontan surgery being 0.20 per 100 patient‐years (95% CI 0.12–0.35) and 3.9% (95% CI 2.2%–6.8%), respectively. Only about 70% of patients with HCC (20/28) had underlying cirrhosis.
Conclusion
The incidence of cirrhosis and HCC increases over time, especially at ≥20 years post Fontan surgery. Studies are needed to further identify at‐risk patients in order to streamline surveillance for these highly morbid conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Liver Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- National Institutes of Health Library, Office of Research Services, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA.
- Office of the Director, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Division of Pediatric Cardiology, Children's National Hospital, Washington, DC, USA.
- Adult Congenital Heart Disease Center, Johns Hopkins Heart and Vascular Institute, Baltimore, Maryland, USA.
- Translational Hepatology Section, Liver Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Asif A Hitawala
Förderung
- National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
- National Institutes of Health Library, Office of Research Services in support of the NIH Intramural Research Program, National Institutes of Health, Bethesda,…
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Hitawala, A. A., Gopalakrishna, H., Mironova, M., Livinski, A. A., Wright, E. C., Downing, T., Ito, S., Fisher, S. D., Cedars, A. M., John, A. S., & Heller, T. (2024). Meta‐analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17952
Vancouver
Hitawala AA, Gopalakrishna H, Mironova M, Livinski AA, Wright EC, Downing T, et al. Meta‐analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.17952
BibTeX
@article{Hitawala2024,
author = {Hitawala, Asif A and Gopalakrishna, Harish and Mironova, Maria and Livinski, Alicia A and Wright, Elizabeth C and Downing, Tacy and Ito, Seiji and Fisher, Stacy D and Cedars, Ari M and John, Anitha S and Heller, Theo},
title = {Meta‐analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
doi = {10.1111/apt.17952}
}
EUVIMED